Evidence map›Paper›PMID 42322430›Full record

ArticleCurrent microbiology2026

Comparative Genomic Analysis of Pseudomonas shahriarae Reveals Virulence Potential, Antimicrobial Resistance, and Environmental Adaptation.

Salih Kumru

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Salih KumruFaculty of Fisheries, Recep Tayyip Erdogan University, Rize, 53020, Turkey. salih.kumru@erdogan.edu.tr.ORCID https://orcid.org/0000-0002-2309-3110

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas shahriarae is a recently identified member of the P. fluorescens group. Its ecological range and ability to cause disease are still mostly unknown, especially in aquaculture settings. This work presents the first genome sequence of P. shahriarae isolated from diseased Siberian sturgeon (Acipenser baerii). To obtain deeper understanding of its evolutionary history, pathogenicity, and capacity of antibiotic resistance, this genome was compared with seven other publicly available genomes. The draft genome of strain SK21 was 6.12 Mb size and had a GC content of 60.5%. Core genome analysis revealed 3,652 conserved genes among strains, and average nucleotide identity values over 98% validated species-level relatedness among the majority of isolates. One strain that was originally thought to be P. shahriarae exhibited only about 83% ANI and grouped with Pseudomonas iridis, which suggests that it was misclassified. A comparative genomic investigation showed that there is a shared set of virulence-associated factors, such as genes that help with adhesion, biofilm formation, motility, immunological regulation, and nutrition acquisition, as well as different secretion systems (T1SS-T6SS). The strain from sturgeon uniquely expressed a full class 1 integron, indicating the acquisition of antimicrobial resistance components by horizontal gene transfer in aquaculture settings. The extensive prophage regions and metabolic flexibility further underscore the adaptability of this species. This work presents the first genomic evidence associating P. shahriarae with sturgeon disease and uncovers a genetically varied bacteria that may impact aquaculture health and the spread of antibiotic resistance.

Indexed as

Adaptation, PhysiologicalDrug Resistance, BacterialGenome, BacterialPseudomonasPseudomonas InfectionsAnimalsAnti-Bacterial AgentsFish DiseasesFishesGenomicsPhylogenyVirulenceVirulence FactorsAnti-Bacterial AgentsVirulence Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.